Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)

TPE:1720 Revenue

Standard Chemical & Pharmaceutical had revenue of 1.87B TWD in the quarter ending June 30, 2026, with 2.44% growth. This brings the company's total for the last twelve months to 7.08B, up 2.85% year-over-year. In the year 2025, Standard Chemical & Pharmaceutical had annual revenue of 7.02B with 3.44% growth. That makes Standard Chemical & Pharmaceutical the 16,848th largest company in the world by revenue and 586th in Taiwan.

• Revenue (ttm): 7.08B
• Revenue Growth: +2.85%
• P/S Ratio: 1.44
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 10.19B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Human medicine 3.31B 45.3%
• Food 2.31B 31.5%
• Active Pharmaceutical Ingredient 1.38B 18.8%
• Others 319.65M 4.4%

By Geography

Chart

• Taiwan 5.50B 78.3%
• Export 1.53B 21.7%

Fiscal year ended Dec 31, 2025 See the full TPE:1720 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.02B	233.80M	3.44%
Dec 31, 2024	6.79B	549.46M	8.81%
Dec 31, 2023	6.24B	388.40M	6.64%
Dec 31, 2022	5.85B	1.25B	27.09%
Dec 31, 2021	4.60B	298.68M	6.94%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error